Stocktoria

Praxis Precision Medicines, Inc. PRAX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-10-16

Praxis Precision Medicines, Inc. statistics & valuation

Market cap$9.1B
P / B10.4×
Return on equity-34.5%
Return on capital-37.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-5164.40% -2340.30% 2019202020212022202320242025
Return on equity (%)
-21.50% -66.60% -281.20% -176.90% -41.00% -34.50% 2019202020212022202320242025
Shares outstanding
1.6M 38.3M 45.3M 3.3M 8.8M 19.4M 25.2M 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-74.50% -20.40% -57.10% -185.90% -140.20% -37.80% -32.30% 2019202020212022202320242025
Free cash flow margin (%)
-4543.80% -1540.50% 2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$7.86 -$3.94 -$69.65 -$18.69 -$10.21 -$13.48 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin—-2340.3%-5164.4%————
Net margin—-2137.5%-5037.9%————
FCF margin—-1540.5%-4543.8%————
Return on assets-32.3%-37.8%-140.2%-185.9%-57.1%-20.4%-74.5%
Return on equity-34.5%-41.0%-176.9%-281.2%-66.6%-21.5%43.8%
Current ratio10.2210.775.393.237.4819.236.67

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.